MaterialsgateNEWS
vom 12.10.2015

Researchers from Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Karp Lab at Brigham and Women's Hospital have jointly designed a specialized catheter for fixing holes in the heart using a biodegradable adhesive and patch.

As the team reports in Science Translational Medicine, the catheter has been used successfully in animal studies to facilitate hole closure without the need for open heart surgery.

Pedro delNido, MD, Chief of Cardiac Surgery at Boston Children's and contributing author on the study, says the device represents a radical change in the way these kinds of cardiac defects are repaired. "In addition to avoiding open heart surgery, this method avoids suturing into the heart tissue, because we're just gluing something to it."

Catheterizations are preferable to open heart surgery because they don't require stopping the heart, putting the patient on bypass, and cutting into the heart. The Heart Center at Boston Children's is committed to pursuing the least invasive methods possible to correct heart defects, which are among the most common congenital defects.

Last winter, the unique adhesive patch was published in Science Translational Medicine. This represented a large step forward in the quest to reduce complications associated with heart defect repair. While medical devices that remain in the body may be jostled out of place or fail to cover the hole as the body grows, the patch allows for heart tissue to create its own closure and then dissolves.

To truly realize the patch's potential, however, the Boston Children's/Wyss/SEAS/Brigham and Women's research team sought a way to deliver the patch without open heart surgery. Their newly designed catheter device utilizes UV light technology and can be used to place the patch in a beating heart.

The catheter is inserted through a vein in the neck or groin and directed to the defect within the heart. Once the catheter is in place, the clinician opens two positioning balloons: one around the front end of the catheter, passing through the hole, and one on the other side of the heart wall.

The clinician then deploys the patch and turns on the catheter's UV light. The light reflects off of the balloon's shiny interior and activates the patch's adhesive coating. As the glue cures, pressure from the positioning balloons on either side of the patch help secure it in place.

Finally, both balloons are deflated and the catheter is withdrawn. Over time, normal tissue growth resumes and heart tissue grows over the patch. The patch itself dissolves when it is no longer needed.

"This really is a completely new platform for closing wounds or holes anywhere in the body," says Conor Walsh, Ph.D., Wyss Institute Core Faculty member, Assistant Professor of Mechanical and Biomedical Engineering at SEAS, founder of the Harvard Biodesign Lab at SEAS, and author on the paper. "The device is a minimally invasive way to deliver a patch and then activate it using UV light, all within a matter of five minutes and in an atraumatic way that doesn't require a separate incision."

SEAS/Wyss Institute's Ellen Roche, Ph.D., co-first author on the paper along with Boston Children's Assunta Fabozzo, M.D., adds that the device is designed to be customizable. For instance, the rate at which the patch biodegrades can be slowed or accelerated depending on how quickly the surrounding tissue grows over it. Further studies will reveal the appropriate lengths of time for different circumstances.

Jeff Karp, Ph.D., a bioengineer at Brigham and Women's Hospital and a co-founder of Gecko Biomedical, developed the glue product in his lab at Brigham and Women's Hospital. Gecko Biomedical will be testing the glue product in humans later this year.

"Our collaboration across hospitals and institutions to find new and minimally invasive applications for this glue in clinical settings is a great multi-disciplinary example," Karp said. "We are translating our discoveries in the lab into solutions for patients."

"The way the glue works in the face of blood is revolutionary. We don't have to stop the heart," says delNido. "This will enable a wide range of cardiac procedures in the future."

Sie wünschen Material- und Technologierecherchen zu diesem Thema?

Mehr zu diesem Thema

The implantation of medical devices is not without risks. Bacterial or fungal infections can occur and the body's strong immune response may lead to the rejection of the implant.

Researchers at Unit 1121 "Biomaterials and Bio-engineering" (Inserm/Strasbourg university) have succeeded in creating a biofilm with antimicrobial, antifungal and anti-inflammatory properties. It may be used to cover titanium implants (orthopaedic prostheses, pacemakers...) prevent or control post-operative infections. Other frequently used medical devices that cause numerous infectious problems, such as catheters, may also benefit.
These results are published in the journal Advanced Healthcare Materials.
Implantable medical devices (prosthesis/pacemakers) are an ideal interface for micro-organisms, which can easily colonize their surface. As such, bacterial infection may occur... mehr

Bioplastics made from protein sources such as albumin and whey have shown significant antibacterial properties, findings that could eventually lead to their use in plastics used in medical applications such as wound healing dressings, sutures, catheter tubes and drug delivery, according to a recent study by the University of Georgia College of Family and Consumer Sciences.

The bioplastic materials could also be used for food packaging.
Researchers tested three nontraditional bioplastic materials--albumin, whey and soy proteins--as alternatives to conventional petroleum-based plastics that pose risks of contamination.
In particular, albumin, a protein found in egg whites, demonstrated tremendous antibacterial properties when blended with a traditional plasticizer such as glycerol.
"It was found that it had complete inhibition, as in no bacteria would grow on the plastic once applied," said Alex Jones, a doctoral student in the department of textiles, merchandising and interiors. "The bacteria wouldn't be able to live on it."
The... mehr

More than 80 percent of microbial infections in the human body are caused by a build–up of bacteria, according to the National Institutes of Health. Bacteria cells gain a foothold in the body by accumulating and forming into adhesive colonies called biofilms, which help them to thrive and survive but cause infections and associated life–threatening risks to their human hosts. These biofilms commonly form on medical surfaces including those of mechanical heart valves, urinary catheters, intravenous catheters, and implants. But a new study reported in the inaugural issue of ACS Biomaterials Science and Engineering demonstrates a powerful, long–lasting repellent surface technology that... mehr

New design from Duke engineers could reduce threat of infection from millions of urinary catheters

For the millions of people forced to rely on a plastic tube to eliminate their urine, developing an infection is nearly a 100 percent guarantee after just four weeks. But with the help of a little bubble-blowing, biomedical engineers hope to bring relief to urethras everywhere.
About half of the time, the interior of long-term urinary catheters become plagued by biofilms—structures formed by colonies of bacteria that are extremely difficult to kill. Once established, it is only a matter of time before the biofilm becomes a welcoming host for other, more dangerous bacteria or begins to choke urine drainage, causing leakage—or even trauma to the patient’s body.
Duke University engineers... mehr